SchwarzEB, ParisiSM, HandlerSM, KorenG, ShevchikG, FischerGS. Counseling about medication-induced birth defects with clinical decision support in primary care. J Womens Health, 2013; 22:817–824.
2.
SchwarzEB, MaselliJ, NortonM, GonzalesR. Prescription of teratogenic medications in the United States ambulatory practices. Am J Med, 2005; 118:1240–1249.
3.
FinerLB, ZolnaMR. Unintended pregnancy in the United States: Incidence and disparities, 2006. Contraception, 2011; 84:478–485.
4.
FinerLB, HenshawSK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health, 2006; 38:90–96.
5.
GilchristVJ, StangeKC, FlockeSA, McCordG, BourguetCC. A comparison of the National Ambulatory Medical Care Survey (NAMCS) measurement approach with direct observation of outpatient visits. Med Care, 2004; 42:276–280.
6.
AkersAY, GoldMA, BorreroS, SantucciA, SchwarzEB. Providers' perspectives on challenges to contraceptive counseling in primary care settings. J Women's Health, 2010; 19:1163–1170.
7.
U.S. Department of Health and Human Services, Health Resources and Services Administration, Office of Women's Health. Women's health curricula: Final report on expert panel recommendations for interprofessional collaborations across the health professions. Rockville, Maryland: U.S. Department of Health and Hunan Services, 2013.
8.
Centers for Disease Control (CDC). U.S. selected practice recommendations for contraceptive use, 2013. MMWR, 2013; 62:1–46. www.cdc.gov/mmwr/preview/mmwrhtml/rr6205a1.htm. 2013 July 15.
9.
Centers for Disease Control (CDC). U.S. medical eligibility criteria for contraceptive use. MMWR, 2010; 59:1–88. www.cdc.gov/mmwr/pdf/rr/rr59e0528.pdf. 2013 July 15.
